Fiscal year 2024 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses DAWN in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named DAWN in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Jeremy Bender | $680,000 | $0 | $2,700,280 | $2,664,697 | $501,800 | $0 | $13,800 | $6,560,577 |
| Chief Executive Officer and President | ||||||||
| Charles York | 541,000 | 0 | 1,530,640 | 1,511,240 | 299,400 | 0 | 13,800 | 3,896,080 |
| Chief Operating Officer and Chief Financial Officer | ||||||||
| Samuel Blackman | 527,000 | 0 | 1,400,680 | 1,381,724 | 291,700 | 0 | 13,800 | 3,614,904 |
| Co-Founder and Head of Research and Development | ||||||||
| Adam Dubow | 455,000 | 0 | 851,960 | 840,954 | 223,900 | 0 | 13,800 | 2,385,614 |
| General Counsel, Chief Compliance Officer and Secretary | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2024 total | FY2023 total | FY2022 total | Δ FY2023→2024 |
|---|---|---|---|---|
| Jeremy Bender | $6,560,577 | $6,913,959 | $5,086,456 | −353,382 |
| Charles York | 3,896,080 | 3,546,093 | 2,319,451 | +349,987 |
| Samuel Blackman | 3,614,904 | 2,485,392 | 2,077,197 | +1,129,512 |
| Adam Dubow | 2,385,614 | 2,773,253 | — | −387,639 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
No insider equity transactions reported since the proxy statement.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Adam Dubow | RSU | 2024-01-05 | — | — | 59,000 | — | $851,960 |
| Samuel Blackman | RSU | 2024-01-05 | — | — | 97,000 | — | 1,400,680 |
| Charles York | RSU | 2024-01-05 | — | — | 106,000 | — | 1,530,640 |
| Samuel Blackman | OPTION | 2024-01-05 | — | — | 148,000 | — | 1,381,724 |
| Jeremy Bender | OPTION | 2024-01-05 | — | — | 286,000 | — | 2,664,697 |
| Charles York | OPTION | 2024-01-05 | — | — | 162,000 | — | 1,511,240 |
| Adam Dubow | OPTION | 2024-01-05 | — | — | 90,000 | — | 840,954 |
| Jeremy Bender | RSU | 2024-01-05 | — | — | 187,000 | — | 2,700,280 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Adam Dubow | $851,960 | $0 | $840,954 | 0.0% |
| Samuel Blackman | 1,400,680 | 0 | 1,381,724 | 0.0% |
| Charles York | 1,530,640 | 0 | 1,511,240 | 0.0% |
| Jeremy Bender | 2,700,280 | 0 | 2,664,697 | 0.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Jeremy Bender | Option | 220,462 | 14.44 | — |
| Jeremy Bender | Option | 143,166 | 16 | — |
| Adam Dubow | RSU | 23,702 | — | 300,304 |
| Charles York | Option | 37,007 | 16 | — |
| Jeremy Bender | Option | 127,091 | 23.41 | — |
| Samuel Blackman | Option | 18,907 | 16 | — |
| Jeremy Bender | RSU | 27,260 | — | 345,384 |
| Samuel Blackman | Option | 37,500 | 23.41 | — |
| Adam Dubow | Option | 46,875 | 23.41 | — |
| Charles York | RSU | 79,500 | — | 1,007,265 |
| Charles York | RSU | 14,066 | — | 178,216 |
| Samuel Blackman | Option | 36,569 | 14.26 | — |
| Charles York | RSU | 5,500 | — | 69,685 |
| Samuel Blackman | RSU | 72,752 | — | 921,768 |
| Adam Dubow | RSU | 44,252 | — | 560,673 |
| Jeremy Bender | RSU | 38,000 | — | 481,460 |
| Charles York | RSU | 18,000 | — | 228,060 |
| Samuel Blackman | RSU | 5,144 | — | 65,174 |
| Adam Dubow | RSU | 14,000 | — | 177,380 |
| Samuel Blackman | RSU | 4,756 | — | 60,259 |
| Jeremy Bender | RSU | 140,252 | — | 1,776,993 |
| Charles York | Option | 124,875 | 14.44 | — |
| Jeremy Bender | Option | 107,523 | 14.26 | — |
| Adam Dubow | Option | 69,375 | 14.44 | — |
| Charles York | Option | 40,898 | 14.26 | — |
| Adam Dubow | Option | 141,632 | 21.14 | — |
| Charles York | Option | 60,425 | 23.41 | — |
| Samuel Blackman | Option | 114,087 | 14.44 | — |
| Jeremy Bender | RSU | 14,256 | — | 180,624 |
| Samuel Blackman | RSU | 11,504 | — | 145,756 |
The objective of our compensation program is to enable us to hire, reward, and retain the world-class talent that we need to execute our strategy and successfully pursue our mission of developing new medicines for people with life-threatening diseases.
| CEO STI target (% of salary) | 60% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Compensia Inc. |
| Clawback policy | True |
| Anti-hedging | True |
| Anti-pledging | True |
| Ratio (CEO : median employee) | 17 : 1 |
|---|---|
| CEO total compensation | $6,560,577 |
| Median employee compensation | $389,481 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| William GrossmanIndependent · Compensation | $45,597 | $0 | $866,300 | — | $0 | $911,897 |
| Habib DableIndependent · Audit · Nominating/Governance | 43,722 | 0 | 866,300 | — | 0 | 910,022 |
| Garry NicholsonIndependent · Board Chair · Compensation · Nominating/Governance | 84,875 | 0 | 278,600 | — | 0 | 363,475 |
| Saira RamasastryIndependent · Audit (Chair) | 61,750 | 0 | 278,600 | — | 0 | 340,350 |
| Natalie HollesIndependent · Compensation (Chair) | 59,250 | 0 | 278,600 | — | 0 | 337,850 |
| John JoseyIndependent · Nominating/Governance (Chair) | 53,625 | 0 | 278,600 | — | 0 | 332,225 |
| Michael GladstoneIndependent · Audit · Not standing for re-election | 51,750 | 0 | 278,600 | — | 0 | 330,350 |
| Scott GarlandIndependent · Audit | 51,750 | 0 | 278,600 | — | 0 | 330,350 |
| Daniel BeckerIndependent · Compensation · Not standing for re-election · Departed during FY | 18,736 | 0 | — | — | 0 | 18,736 |
| Jeremy BenderEmployee director | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | — |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 20,000 / 15,000 / 10,000 |
| Stock ownership guideline | — |
| Component | FY2024 |
|---|---|
| Cash retainers and fees | $471,055 |
| Equity awards (grant-date value) | $0 |
| All other compensation | $0 |
| Total cost of the board | $471,055 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Day One Biopharmaceuticals | 2024 | Jeremy Bender | $680,000 | $2,700,280 | $2,664,697 | $501,800 | $6,560,577 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Jeremy Bender | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Summary Compensation Table”. As printed: 6,560,577. Filing ↗machine: r2 · c21 · span 526324–526333 |
| 2 | Section 01, Charles York | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Summary Compensation Table”. As printed: 3,896,080. Filing ↗machine: r5 · c21 · span 538024–538033 |
| 3 | Section 01, Samuel Blackman | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Summary Compensation Table”. As printed: 3,614,904. Filing ↗machine: t131 · r8 · c21 · span 549242–549251 |
| 4 | Section 01, Adam Dubow | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Summary Compensation Table”. As printed: 2,385,614. Filing ↗machine: r11 · c21 · span 560991–561000 |
| 5 | Section 03, Adam Dubow RSU | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “TABLE OF CONTENTS EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t129 · r5 · c6 · span 484555–484561 |
| 6 | Section 03, Samuel Blackman RSU | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “TABLE OF CONTENTS EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t129 · r4 · c6 · span 482741–482747 |
| 7 | Section 03, Charles York RSU | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “TABLE OF CONTENTS REPORT OF THE COMPENSATION COMMITTEE” · grants of plan-based awards table. Filing ↗machine: t131 · r5 · c12 · span 536567–536576 |
| 8 | Section 03, Samuel Blackman OPTION | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t138 · r9 · c27 · span 622404–622413 |
| 9 | Section 03, Jeremy Bender OPTION | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t138 · r3 · c27 · span 592534–592543 |
| 10 | Section 03, Charles York OPTION | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t138 · r6 · c27 · span 607802–607811 |
| 11 | Section 03, Adam Dubow OPTION | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t138 · r12 · c27 · span 637747–637754 |
| 12 | Section 03, Jeremy Bender RSU | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “TABLE OF CONTENTS EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t129 · r2 · c6 · span 478973–478980 |
| 13 | Section 07, pay ratio | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “CEO Pay Ratio”. As printed: 17 : 1. Filing ↗machine: span 1008195–1008197 |
| 14 | Section 08, William Grossman | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Director Compensation”. As printed: 911,897. Filing ↗machine: t69 · r6 · c9 · span 252504–252511 |
| 15 | Section 08, Habib Dable | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Director Compensation”. As printed: 910,022. Filing ↗machine: t69 · r3 · c9 · span 246728–246735 |
| 16 | Section 08, Garry Nicholson | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Director Compensation”. As printed: 363,475. Filing ↗machine: t69 · r9 · c9 · span 257974–257981 |
| 17 | Section 08, Saira Ramasastry | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Director Compensation”. As printed: 340,350. Filing ↗machine: t69 · r10 · c9 · span 259892–259899 |
| 18 | Section 08, Natalie Holles | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Director Compensation”. As printed: 337,850. Filing ↗machine: t69 · r7 · c9 · span 254238–254245 |
| 19 | Section 08, John Josey | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Director Compensation”. As printed: 332,225. Filing ↗machine: t69 · r8 · c9 · span 256246–256253 |
| 20 | Section 08, Michael Gladstone | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Director Compensation”. As printed: 330,350. Filing ↗machine: t69 · r5 · c9 · span 250469–250476 |
| 21 | Section 08, Scott Garland | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Director Compensation”. As printed: 330,350. Filing ↗machine: t69 · r4 · c9 · span 248724–248731 |
| 22 | Section 08, Daniel Becker | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Director Compensation”. As printed: 18,736. Filing ↗machine: t69 · r2 · c3 · span 243817–243823 |
| 23 | Section 08, Jeremy Bender | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 24 | Section 01 trend, Δ column (computed) | Computed | — | computed | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 25 | Section 03b vehicle mix (computed) | Computed | — | computed | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 26 | Section 09b board cost (computed) | Computed | — | computed | Cash 471,055 + equity 0 + all other 0 = 471,055, summed across the director compensation table rows.machine: formula: Σ = 471,055 |
| 27 | Day One Biopharmaceuticals (subject), Section 10b CEO total | DEF 14A | 2025-04-11 | 0001140361-25-013462 | CEO total compensation as printed in Day One Biopharmaceuticals's own proxy. As printed: 6,560,577. Filing ↗machine: r2 · c21 · span 526324–526333 |